期刊文献+

糖尿病肾病治疗的循证医学新进展 被引量:12

New advancements of evidenced-based medical treatment of diabetic nephropathy
原文传递
导出
摘要 随着糖尿病(DM)发病率的逐年上升,糖尿病肾病(DN)已成为引起我国乃至全球终末期肾病的一个主要原因,因此其治疗问题也成为临床肾脏病学界的一个重要焦点。近年来,DN治疗的循证医学研究取得了一些新的进展,如合理地控制血糖、血压,调节血脂,降低蛋白尿,保护肾功能等治疗措施的更新,在一定程度上改变了人们以往对DN治疗的认识。对防治DN并发症,延缓DN进展,降低患者心血管疾病及死亡发生率具有重要的临床价值。该文结合文献资料及我们以往的工作对DN治疗循证医学新进展予以综述。 With the increasing incidence of diabetes mellitus (DM) year by year, diabetic nephropathy (DN) has become one of the major causes of end-stage renal disease in the world. Therefore, its medical treatment has become the focus of attention. Recently, new advancements in evidence- based treatment of DN have been shown in reasonably controlling hyperglycemia, hypertension, dyslipidemia, reducing proteinuria, and protecting renal function. These measures have updated the previous recognition of treatments, and have significant clinical value in prevention and treatment of complications, slowing down the progression of DN, and reducing the incidence of cardiovascular diseases and death. Here we reviewed the new advancements of evidenced-based treatment of diabetic nephropathy according to the related publications.
作者 韩雅纯 孙林
出处 《中华肾病研究电子杂志》 2015年第5期29-34,共6页 Chinese Journal of Kidney Disease Investigation(Electronic Edition)
基金 国家自然科学基金(81270812 81370832 81470960)
关键词 糖尿病肾病 循证医学 治疗 Diabetic nephropathy Evidence- based medicine Treatment
  • 相关文献

参考文献55

  • 1Breyer MD, Coffman TM, Flessner MF, et al. Diabetic nephropathy: a national dialogue [ J ]. Clin J Am Soc Nephrol, 2013, 8 (9): 1603-1605.
  • 2Liu ZH. Nephrology in China [J]. Nat Rev Nephr01, 2013,9 (9) : 523-528.
  • 3Sandbaek A, Griffin SJ, Sharp SJ, et al. Effect of early multifaetorial therapy compared with routine care on microvascular outcomes at 5 years in people with screen-detected diabetes: a randomized controlled trial: the ADDITION-Europe Study [J]. Diabetes Care, 2014, 37 (7) : 2015-2023.
  • 4Stratton IM, Adler AI, Nell HA, et al. Association of glycaemia with macrovascular and mierovascular complications of type 2 diabetes ( UKPDS 35 ) : prospective observational study [J]. BMJ, 2000, 321 (7258) : 405-412.
  • 5Zhang Y, Hu G, Yuan Z, et al. Glycosylated hemoglobin in relationship to cardiovascular outcomes and death in patients with type 2 diabetes : a systematic review and meta- analysis [ J ]. PLoS One, 2012, 7 (8) ~ e42551.
  • 6The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus [J]. N Engl J Med, 1993, 329 (14) : 977-986.
  • 7de Boer IH, Sun W, Cleary PA, et al. Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes [ J]. N Engl J Med, 2011, 365 (25): 2366-2376.
  • 8Udell JA, Cavender MA, Bhatt DL, et al. Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials [J]. Lancet Diabetes Endocrinol, 2015, 3 (5): 356-366.
  • 9Lind M, Svensson AM, Kosiborod M, et al. Glycemic control and excess mortality in type 1 diabetes [J]. N Engl J Med, 2014, 371 (21) : 1972-1982.
  • 10Gerstein HC, Miller ME, Genuth S, et al. Long-term effects of intensive glucose lowering on cardiovascular outcomes [J]. N Engl J Med, 2011, 364 (9) : 818-828.

同被引文献111

引证文献12

二级引证文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部